Login
Boston Scientific Corp. NYSE: BSX
Boston Scientific Corp. develops, manufactures, and markets medical devices in the Cardiovascular, Rhythm Management, and MedSurg segments
| Name | Boston Scientific Corp. |
| Ticker | BSX |
| Exchange | NYSE |
| Sector | Health Care |
| Industry | Specialized Medical Devices |
| Price | 37.34 |
| 52W Low/High | 25.83 / 45.71 |
| Market cap | 52 B |
| 1Y Total Return |
-7.37%
Average |
| 1Y Volatility |
43.53%
Low Risk |
Relative Strength Index : Attempt to identify overbought (above 80) and oversold (below 20) conditions
Boston Scientific Corp. develops, manufactures, and markets medical devices in the Cardiovascular, Rhythm Management, and MedSurg segments
Details
| Ticker | BSX |
| Name | Boston Scientific Corp. |
| ISIN | US1011371077 |
| CUSIP | 101137107 |
| Exchange | NYSE |
| Sector | Health Care |
| Industry | Specialized Medical Devices |
| Country | USA |
| Currency | U.S. Dollar |
| In Index(ices) | US S&P 500 Index |
Share as of 9/25/20
| Close Price | 37.34 |
| 52W Low/High | 25.83 / 45.71 |
| Market cap | 52 B |
| 1Y Total Return |
-7.37%
Average |
| 1Y Volatility |
43.53%
Low Risk |
| Beta | 0.53 |
| PE (trailing) |
13.24
Below Average |
| 12M Dividends | - |
| Last Dividend Date | - |
| Dividend Yield | - |
Fin. Strength
| Net Profit Margin | 39.2% |
| Cash from Op. / Cur. Liabilities | 0.45 |
| Diluted Earnings / Share | 2.82 |
| ROE | 31.8% |
| ROIC | 6.7% |
| Price / Revenue | 5.2 |
| Price / Book | 3.4 |
| Price / CF | 38.1 |
| Current Ratio | 1.9 |
| Cur.Liabilities / Tot.Liabilities | 0.2 |
| Financial Leverage | 0.61 |
| in Mils USD |
rolling-year up to June
|
||||||
|---|---|---|---|---|---|---|---|
| Income Statement | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
| Revenue |
10,157
|
10,078
|
9,499
|
8,713
|
7,956
|
7,344
|
|
| Gross Profit |
6,932
|
7,189
|
6,777
|
6,218
|
5,632
|
5,175
|
|
| R&D |
1,156
|
1,137
|
1,053
|
967
|
897
|
832
|
|
| EBITDA |
1,391
|
2,568
|
2,281
|
1,788
|
130
|
503
|
|
| Operating Income |
669
|
1,633
|
1,494
|
1,077
|
-567
|
-185
|
|
| Net Income exc. Extra |
3,985
|
1,396
|
521
|
788
|
-
|
-
|
|
| per Share | |||||||
| Diluted avg Shares |
1,411
|
1,409
|
1,399
|
1,391
|
1,357
|
1,362
|
|
| EPS exc. Extra |
2.82
|
0.99
|
0.37
|
0.58
|
-0.26
|
-0.11
|
|
| Dividend |
-
|
-
|
-
|
-
|
-
|
-
|
|
| Div. Yield (an.) |
-
|
-
|
-
|
-
|
-
|
-
|
|
| Balance Sheet | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
| Total Assets |
30,823
|
24,309
|
19,615
|
18,382
|
17,838
|
17,123
|
|
| Cash, Eq & Invt ShortTerm |
1,724
|
123
|
208
|
195
|
438
|
903
|
|
| Total Current Assets |
5,803
|
6,334
|
3,929
|
3,222
|
3,330
|
3,773
|
|
| Total Non-Current Assets |
25,020
|
17,975
|
15,686
|
15,160
|
14,508
|
13,350
|
|
| Intangibles |
17,261
|
14,937
|
13,176
|
12,792
|
12,405
|
11,372
|
|
| Total Liabilities |
15,207
|
14,884
|
11,871
|
11,147
|
11,618
|
10,543
|
|
| Total Current Liabilities |
3,108
|
4,850
|
4,753
|
4,300
|
3,182
|
1,937
|
|
| Long Term Debt |
12,099
|
10,034
|
7,118
|
6,847
|
8,436
|
8,606
|
|
| Shareholder equity |
15,616
|
9,425
|
7,744
|
7,235
|
6,220
|
6,580
|
|
| Cash Flow | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
| Cash from Operations |
1,386
|
1,162
|
926
|
935
|
1,365
|
649
|
|
| Depreciation |
1,011
|
894
|
844
|
815
|
769
|
725
|
|
| Cash from Investing |
-4,146
|
-2,287
|
-1,055
|
-1,356
|
-2,039
|
-853
|
|
| Capex |
369
|
320
|
273
|
418
|
264
|
227
|
|
| Cash from Financing |
1,951
|
2,959
|
649
|
379
|
256
|
756
|
|
| Stock Issued |
1,022
|
46
|
39
|
14
|
57
|
31
|
|
| Debt (LT) Issued |
-141
|
2,992
|
629
|
413
|
304
|
831
|
|
| Free Cash Flow |
-1,143
|
2,150
|
916
|
2,581
|
2,051
|
-1,278
|
|
| Ratios | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
| Net Profit Margin |
39.2%
|
13.9%
|
5.5%
|
9.0%
|
-
|
-
|
|
| NCFO / Op.Income |
207.2%
|
71.2%
|
62.0%
|
86.8%
|
-
|
-
|
|
| Current Ratio |
1.9
|
1.3
|
0.8
|
0.7
|
1.0
|
1.9
|
|
| Financial Leverage D/E |
0.61
|
1.01
|
0.84
|
0.81
|
0.87
|
0.78
|
|
| Return on Capital Avg |
6.7%
|
10.2%
|
0.8%
|
6.6%
|
0.3%
|
-10.2%
|
|
| Return on Shareholder Equity |
31.8%
|
16.3%
|
7.0%
|
11.7%
|
-
|
-
|
|
Fundamentals
No documents are available for the moment, please check back soon, or save the asset to be notified when documents are available